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Background: Several case–control studies have been conducted to clarify the association between the tumor
necrosis factor alpha (TNF-α) -G308A polymorphism and risk of osteoarthritis (OA); however, the results are
inconsistent. This meta-analysis was performed to clarify this issue using all the available evidence.
Methods: Eligible articles were retrieved by searching PubMed, Web of science and Google scholar. The strength
of the association between the TNF-α -G308A polymorphism and risk of OA was assessed by odds ratios (ORs) with
the corresponding 95% confidence interval (CI) for each study.
Results: Seven studies were included in the meta-analysis, which included 983 OA cases and 1355 controls. The
pooled analysis based on all included studies showed a significantly increased OA risk in the recessive genetic
model analysis (OR = 11.08, 95% CI = 4.75-25.86, p < 0.001) and in the A allele vs. G allele analysis (OR = 2.30,
95% CI = 1.08-4.90). However, there was no statistical difference in the dominant genetic model analysis (OR = 2.45,
95% CI = 0.95-6.27, p = 0.06). Furthermore, we found that OA patients had a higher frequency of the AA genotype
(OR = 10.49, 95% CI = 4.47-24.61) and GA genotype (OR = 1.78, 95% CI = 1.03-3.08) compared with the control
population.
Conclusion: Our results suggested that the TNF-α -G308A polymorphism were associated with an increased risk of OA.
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As one of the most common age-related disease leading to
restrictions in daily activities of the elderly, osteoarthritis
(OA) is set to become the 4th-highest impact condition in
women and the 8th-highest in men. The prevalence of OA
is steadily increasing across all age groups [1]. Given the
high morbidity and huge economic burden of OA, there is
an urgent need to define the pathogenic factors involved
in OA development. OA is a multistep, multifactorial dis-
ease that involves a complex interplay between genetic
and environmental factors. Besides the traditional com-
mon risk factors, such as aging, obesity, previous injury,
smoking habit and hormone therapy [2], recent studies
have revealed that inflammatory processes play a pivotal
role in OA pathogenesis [3]. Proinflammatory cytokines
are now implicated as important mediators in OA, and* Correspondence: wuyaochi2014@163.com
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unless otherwise stated.TNF-α and interleukin 1 beta (IL-1β) are considered the
major factors.
TNF-α is a multifunctional pro-inflammatory cyto-
kine involved in various physiological and pathological
processes, including inflammation, immunoregulation,
proliferation and apoptosis [4]. TNF-α is produced by
chondrocytes, mononuclear cells, osteoblasts and synovial
tissues, and can stimulate its own production and induce
chondrocytes and synovial cells to produce other cyto-
kines. TNF-α also induces osteoclastic bone resorption [5]
and destruction of cartilages [6]. Elevated levels of TNF-α
have been found in the synovial fluid, synovial membrane,
subchondral bone and cartilage of OA patients [7,8], con-
firming its important roles in OA pathogenesis.
Genetic variations within the TNF-α promoter could
alter the transcription and translation of TNF-α [9]. Poly-
morphisms in the promoter region of TNF-α have been
found at -G238A, −G308A, −C863A, and -C857A, among
which, the -G308A polymorphism is the most commonly
studied. Previous studies found that the expression ofLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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http://www.biomedcentral.com/1471-2474/15/373TNF-α is higher in patients carrying the -308A allele than
in those carrying the -308G allele, suggesting that this
polymorphism has functional implications in inflamma-
tion and may be associated with inflammatory diseases
[10]. In fact, previous studies have demonstrated the asso-
ciation of this polymorphism with certain inflammatory
diseases, such as fatty liver disease [11], hepatitis B virus
infection [12], systemic lupus erythematosus [13], inflam-
matory bowel disease [14], arteritis [15] and rheumatoid
arthritis [16]. Several case–control studies have been
conducted to clarify the association between the TNF-
α -G308A polymorphism and risk of OA [17-23]; how-
ever, the results are inconsistent. Han’s study [20] and Ji’s
study [22] found that the frequency of A allele was sig-
nificantly higher in the OA cases; however, Sezgin’s study
[19] and Valle’s study [21] found no association between
the TNF-α -G308A polymorphism and OA risk. In view
of the uncertain association between TNF-α -G308A poly-
morphism and OA risk, we sought to obtain more precise
information by conducting a meta-analysis including all of
the evidence produced to date.
Methods
Search strategy
Eligible articles were retrieved by searching the PubMed
bibliographical database, Web of science and Google
scholar (up to January 16, 2014) using the following com-
bination of keywords: (tumour necrosis factor-alpha) OR
(tumour necrosis factor-α) OR (TNF-α)); OA OR osteo-
arthritis; polymorphism OR polymorphisms OR variants
OR variant. In addition, we checked the references in
reviews and in the retrieved articles to avoid missing any
relevant studies. There was no restriction on language in
the search. The article selection was carried out by both
YW and SK independently to minimize bias and human
error.
Inclusion and exclusion criteria
To be included in this meta-analysis, an article had to
provide the following information: 1) the number of OA
cases and controls; and 2) the number of individuals
with GG, GA and AA in both OA cases and controls.
Those not designed as case–control studies, systemic
reviews, and those that provided no usable data were
excluded.
Data extraction
Two independent reviewers used a predesigned data
extraction table to extract the data. The following infor-
mation was extracted from each included article: journal
name, first author, publication year, ethnicity and coun-
try, OA phenotype, source of controls, the number of
genotypes in OA cases and controls, and the results of
the study. Disagreement was resolved by discussion.Statistical analysis
The strength of the association between the TNF-α -G308A
polymorphism and risk of OA was assessed by odds ratios
(ORs) with the corresponding 95% confidence interval
(CI) for each study. The ORs and their 95% CIs were as-
sessed for the following genetic models: 1) the dominant
genetic model (AA +GA vs. GG) (A stands for the minor
allele and G stands for the major allele); 2) the recessive
genetic model (AA vs. GA +GG) and 3) the allele A vs.
allele G analysis. The genotype frequencies of GG, GA
and, AA were also assessed using the same method. A
chi-squared (χ2) test was used to assess heterogeneity
across studies. A fixed effect model was used when no
heterogeneity existed among the studies. Otherwise, a
random effect model was used. Meta-regression analysis
was performed to find any sources of heterogeneity.
Subgroup analysis for ethnicity (Asian and Caucasian),
design type (HCC (hospital based case–control study)
and PCC (population based case–control study)) and
sample size (smaller (total sample <300) and larger (total
sample ≥300)) was conducted. Potential publication bias
was assessed using a funnel plot, and calculated using
Begg’s and Egger’s tests (P < 0.05 was considered as signi-
ficant publication bias). Influence analysis was performed
by omitting each study to find potential outliers. In the
control populations, the Hardy-Weinberg equilibrium
(HWE) was tested using a chi- squared (χ2) test. Two
authors performed the statistical analysis independently
and obtained the same results. STATA software (version
11; Stata Corporation, College Station, TX, USA) was used
to perform the statistical analyses. P values less than 0.05
were considered statistically significant.
Results
Literature selection and study characteristics
A total of 506 articles were retrieved from PubMed,
Web of science and Google Scholar, 492 of which were
excluded after screening the titles and abstracts (469
were irrelevant studies and 23 were duplicate studies).
Fourteen articles were selected for detailed assessment
and seven of them were excluded (three were not about
G308A, three were not about OA risk and one had no
usable data). Finally, seven studies were included in this
meta-analysis, which included 983 OA cases and 1355
controls. The detailed selection procedure is shown in
Figure 1. Genotype distributions in the controls of Moos’s
study [17] were not in agreement with HWE. Most of the
cases were knee OA, only one study recruited some hip
OA cases [17]. The detailed characteristics of the included
studies are shown in Table 1.
Quantitative data synthesis
The pooled analysis based on all included studies showed
a significantly increased risk in the recessive genetic model
Figure 1 Flowchart of the study selection.
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(Figure 2B) and in the A allele vs. G allele analysis
(OR = 2.30, 95% CI = 1.08-4.90, p < 0.001) (Figure 2C).
However, there was statistically non-significant ten-
dency towards decreased risk in the dominant genetic
model analysis (OR = 2.45, 95% CI = 0.95-6.27, p = 0.06)
(Figure 2A).We then assessed the genotype frequencies
based on all included studies. The results showed that
OA patients had a higher frequency of the AA genotype
(OR = 10.49, 95% CI = 4.47-24.61, p = 0.001) (Figure 3A)
and GA genotype (OR= 1.78, 95% CI = 1.03 -3.08, p = 0.006)
(Figure 3B) compared with the control population. How-
ever, there was no significant difference for the GG geno-
type (OR = 0.77, 95% CI = 0.53-1.12, p = 0.14) (Figure 3C).
The detailed results are shown in Table 2.
Tests of heterogeneity and subgroup analysis
We found heterogeneities in the dominant genetic model
analysis (p < 0.01). A random effects model was adopted in
these two analyses. Furthermore, a meta-regression analysis
was conducted to find potential sources of heterogeneities.Table 1 Characteristics of studies included in TNF-α polymorp
Study Ethnicity Design Phenotype HWE Total cases
Moos 2000 [17] Caucasian HCC Knee/Hip No 55
Romero 2002 [18] Caucasian HCC Knee Yes 31
Sezgin 2008 [19] Caucasian HCC Knee Yes 151
Han 2012 [20] Asian PCC Knee Yes 301
Valle 2012 [21] Caucasian PCC Knee Yes 50
Ji 2013 [22] Asian PCC Knee Yes 200
Cheng 2013 [23] Asian PCC Knee Yes 200
HCC Hospital based case–control study, PCC population based case–control study. HUnfortunately, the common variables, such as publication
year, ethnicity, study design type and sample size were not
significant sources of heterogeneities. However, we still
performed subgroup analysis based on ethnicity, study
design type (HCC or PCC,) and total sample size, because
such subgroup analysis was valuable. The detailed results
are shown in Table 2.
Sensitivity analysis
Influence analysis was performed to assess the sensitivity
of each individual study on the pooled ORs, by sequen-
tial omission of each individual study. The results sug-
gested that Han’s study [20] significantly affected almost
all of the pooled ORs (Figure 4A-C). Therefore, we cal-
culated the results again with Han’s study [20] omitted.
The results are shown in Table 3 and Additional file 1:
Figure S1; Additional file 2: Figure S2. The pooled ana-
lysis showed an increased risk in all three analyses: the
dominant model analysis (OR = 1.72, 95% CI = 1.35 -2.20,
p < 0.001), the recessive model analysis (OR = 4.84, 95%
CI = 1.90 -12.35, p = 0.001) and A allele vs. G allele analysis
(OR = 1.75, 95% CI = 1.40 -2.19, p < 0.001) (Additional
file 1: Figure S1A-C). We also re-assessed the genotype
frequency of GG, GA and AA; however, the results
were almost the same as those including all the studies
(Additional file 2: Figure S2A-C).
Publication bias
Funnel plots were used to estimate qualitatively the
potential publication bias. Taking the the recessive model
analysis and A allele vs. G allele analysis as examples, the
shapes of the funnel plots did not indicate any obvious
asymmetry (Figure 5A,B). Furthermore, Begg’s and Egger’s
tests were used to estimate quantitatively the potential
publication bias. The p values were all greater than 0.05,
indicating no publication bias.
Discussion
To the best of our knowledge, this is the first meta-analysis
to evaluate the association between the TNF-α -308
polymorphism and risk of OA. In this meta-analysis, wehisms and osteoarthritis
Total controls GG GA AA
Cases Controls Cases Controls Cases Controls
240 36 166 18 74 1 0
30 28 28 3 2 0 0
84 121 72 26 12 4 0
291 79 258 188 33 34 0
100 44 93 6 7 0 0
305 143 253 50 50 7 2
305 143 253 50 49 7 3
WE Hardy-Weinberg equilibrium.
Figure 2 Meta-analysis of TNF-α -308 polymorphism and OA risk: (A) dominant genetic model analysis; (B) recessive genetic model
analysis (C) A allele vs. G allele analysis. Note: No AA genotype in Romero’s study and Valle’s study, therefore, these two studies were excluded in
the recessive model analysis.
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model analysis and in the A allele vs. G allele analysis.
Furthermore, we found a higher frequency of the AA
and GA genotype in OA patients.
TNF-α is a potent pro-inflammatory cytokine in in-
flammatory diseases and the immune response. Higher
levels of TNF-α were found in OA patients compared
with the control population [24]. TNF-α can induce the
production of other cytokines, matrix metalloproteinases
and prostaglandins 9, and inhibit the synthesis of proteo-
glycans and type II collagen; thus it plays a pivotal role
in cartilage matrix degradation and bone resorption in
OA [25,26]. Single nucleotide conversion from guanine
(G) to adenine (A) at position −308 is the most common
polymorphism in general populations and this transition
has been shown to influence the expression of TNF-α.
According to previous study, the −308 allele A is associ-
ated with about 6 fold increased transcriptional activity
and higher protein levels of TNF-α [27]. Valle’s study [21]
also found that OA patients with −308 GG genotypeexpressed less TNF-α mRNA than patients with the GA
genotype. Therefore, the TNF-α -308 polymorphism may
have some effect on the hosts’ susceptibility to OA by
altering TNF-α expression. In support of this, our meta-
analysis found an increased risk of OA in the AA vs. GG
analysis and the recessive model analysis, and higher fre-
quencies of the AA and GA genotypes in OA patients.
However, by subgroup analysis, we found that the re-
lationship of TNF-α-308 polymorphism and OA risk
only existed among Asian population but not among
Caucasion population. In recent GWAS studies, 11 OA
susceptibility loci with genome-wide significance levels
was indentified. Among them, a region containing HLA
class II/III genes, which close to the region habouring
TNF gene, showed association in Asians but not in
Europeans [28-30], other nine loci reached genome-wide
significance in Europeans[31]. These findings exactly ex-
plained why the relationship of TNF-α-308 polymorphism
and OA risk only existed among Asian population but not
among Caucasion population.
Figure 3 Meta-analysis of TNF-α -308 genotypes and OA risk: (A) AA genotype frequency; (B) GA genotype frequency; (C) GG genotype
frequency. Note: No AA genotype in Romero’s study and Valle’s study, therefore, these two studies were excluded in AA frequency analysis.
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have significantly affected the results; however, when omit-
ting Han’s study, the conclusions showed good consistency
with the previous results. Therefore, the conclusions from
our meta- analysis are sound and reliable.Table 2 Summary ORs and 95% CIs of TNF-α polymorphism a
Analysis n Dominant model(GA + AA vs.GG) R
OR(95% CI) P/Phet
Overall 7 2.45(0.95-6.27) 0.06/0.00 11
Ethnicity
Caucasian 2 1.37(0.89-2.10) 0.14/0.92 6
Asian 3 4.35(0.91-20.92) 0.07/0.00 11
Study design
HCC 2 1.31(0.83-2.08) 0.24/0.89 6
PCC 3 3.58(0.94-13.62) 0.06/0.00 11
Sample size
Smaller 2 1.37(0.89-2.10) 0.14/0.92 6
Larger 3 4.35(0.91-20.92) 0.07/0.00 11
n, number of studies in each analysis; HCC, Hospital based case–control study; PCC,
p, p value for each test; Phet, p -value for heterogeneity test.Recently, we have noticed that some studies have been
conducted to explore the efficacy of anti-TNF therapy
on OA. Güler-Yüksel’s study have found that treatment
with TNF-α inhibitor might reduce hand OA in patients
with rheumatoid arthritis[32], which shed light to thend osteoarthritis
ecessive model(AA vs.GG + GA) A allele vs. G allele
OR(95% CI) P/Phet OR(95% CI) P/Phet
.08(4.75-25.86) 0.00/0.25 2.30(1.08-4.90) 0.03/0.00
.99(0.70-69.68) 0.10/0.66 1.42(0.96-2.09) 0.08/0.89
.85(4.77-29.48) 0.00/0.07 3.59(1.06-12.18) 0.04/0.00
.99(0.70-69.68) 0.10/0.66 1.38(0.91-2.08) 0.13/0.79
.85(4.77-29.48) 0.00/0.07 3.10(1.08-8.87) 0.04/0.00
.99(0.70-69.68) 0.10/0.66 1.42(0.96-2.09) 0.08/0.89
.85(4.77-29.48) 0.00/0.07 3.59(1.06-12.18) 0.04/0.00
population based case–control study; OR, odds ratio; CI, confi dence interval;
Figure 4 Influence analysis for TNF-α -308 polymorphism in the overall analysis: (A) dominant model analysis; (B) recessive model
analysis; (C) A allele vs. G allele analysis. These figures show the influence of individual studies on the pooled ORs. The middle vertical axis
represents the overall ORs and the two vertical axes represent its 95% CIs. Open circles represent the pooled OR when the selected study is
omitted in this meta-analysis. The two ends of the dotted lines indicate the 95% CI.
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recently published RCT failed to confirm the efficacy of
anti-TNF-α in treatment of primary hand OA [33], and
the author speculated that TNF α is not the right target
in order to improve symptoms in hand OA and TNF αTable 3 Summary ORs and 95% CIs after ommiting Han’s
study
Analysis OR(95% CI) p value Phet
Dominant model 1.72(1.35-2.20) <0.001 0.82
Recessive model 4.84(1.90-12.35) 0.001 0.90
A allele vs. G allele 1.75(1.40-2.19) <0.001 0.8
GG frequency 0.89(0.77-1.04) 0.14 0.99
GA frequency 1.41(1.10-1.80) 0.006 0.91
AA frequency 4.72(1.85-12.03) 0.001 0.90
Dominant model: GA + AA vs. GG; Recessive model, AA vs. GA + GG; p, p value
for test; Phet, p value for heterogeneity test.blockers may exert a differential effect on pain and
structure. However, we just have different opinions.
We suppose that anti-TNF-α treatment may be more
efficient in patients with −308 allele A genotype because
the −308 allele A is associated with about 6 fold increased
transcriptional activity and higher protein levels of TNF-α.
Therefore, the detection of −308 polymorphism of TNF-α
is necessary before the treatment of TNF-α blocker. Fur-
ther studies are needed to confirm our speculation.
Although the primary results of our meta-analysis are
suggestive, some limitations may still exist. Firstly, there
was heterogeneity between studies of the −308 poly-
morphism and the heterogeneity may have distorted the
meta-analysis. Unfortunately, meta-regression analysis
failed to find the potential heterogeneity. In addition, no
quality tool has been used to assess the risk of bias in
the included studies, study quality could be one factor
missing from the heterogeneity analysis. Secondly, the
Figure 5 Funnel plot of TNF-α -308 genotypes and OA risk for publication bias: (A) recessive model analysis; (B) A allele vs. G allele.
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Caucasian-specific meta-analysis was low. This study
may not have enough power to explore the association
between the TNF-α -308 polymorphism and risk of OA
in the Caucasian population. Thirdly, the results of the
meta-analysis were based on unadjusted estimates owing
to the lack of adjusted estimates. Currently, some risk
factors have been identified, such as aging, obesity, pre-
vious injury, smoking habit and hormone therapy. A
more precise analysis could be performed if these data
were available. Finally, gene-gene interactions were not
fully addressed in the meta-analysis because of the lack
of relevant data. In fact, the TNF-α gene is located close
to the human leucocyte antigen (HLA) class II/III re-
gion, in which some SNPs, such as rs7775228 and
rs10947262, have been identified as associated with risk
of knee OA [30,34]. Therefore, the positive results from
our meta-analysis may result from the linkage dis-
equilibrium of the proximal susceptible SNPs. Further
studies on the all SNPs in this region and OA risk are
needed.
Conclusions
In conclusion, this comprehensive meta-analysis has eval-
uated all published data currently available on the TNF-α
-308 polymorphism and risk of OA. Our meta-analysis
suggested that the AA and GA genotypes might increase
the risk of OA compared with the GG genotype, which
may be explained by the higher expression of TNF-α in
the -308A allele carriers than in the -308G carriers.Additional files
Additional file 1: Figure S1. Meta-analysis of TNF-α -308 polymorphism
and OA risk after omitting Han’s study: (A) dominant genetic model analysis;
(B) recessive genetic model analysis; (C) A allele vs. G allele analysis.
Additional file 2: Figure S2. Meta-analysis of TNF-α -308 genotypes
and OA risk after omitting Han’s study: (A) AA genotype frequency; (B)
GA genotype frequency; (C) GG genotype frequency.Abbreviations
TNF-α: Tumor necrosis factor alpha; OA: Osteoarthritis; OR: Odds ratio;
CI: Confidence interval; IL-1β: Interleukin 1 beta; HCC: Hospital based
case–control study; PCC: Population based case–control study;
HWE: Hardy-Weinberg equilibrium; HLA: Human leucocyte antigen.
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